SSI Strategy Announces Investment from Amulet Capital Partners

SSI Strategy Holdings LLC (“SSI Strategy” or the “Company”), a leading Life Sciences consultancy, announced today that it has received a growth investment from Amulet Capital Partners, LP (“Amulet”), a middle-market private equity firm focused exclusively on the Healthcare sector. Amulet’s investment, the first institutional funding taken by the Company, will accelerate the growth of SSI Strategy’s team and the expansion of strategic services to support Medical, Clinical and other critical path functions at the C-level of Life Sciences companies.